Rallybio RLYB
NASDAQ RLYB
$17.20 -0.02 (-0.12%)
At close: Sep 30, 2026 · 4:00 PM EDT

Rallybio (RLYB) Capital Expenditures (2020 - 2023)

Updated

Rallybio's Capital Expenditures came in at $12,000 for Q4 2023.

Analysis

Rallybio (RLYB) Capital Expenditures (2020 - 2023) Analysis & Trends

Going back to Q3 2020, Rallybio's Capital Expenditures data covers 10 quarters.

  • Capital Expenditures carries a three-year compound annual growth rate of -55.6% (FY2020 to FY2023).
  • Going back by year, Capital Expenditures was $54,000 in FY2022 (-83.8%), $333,000 in FY2021 (+143.1%) and $137,000 in FY2020.
  • The Q4 2023 figure represents the highest quarterly Capital Expenditures since Q2 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.32 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 322.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 893.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -321.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -763.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 513.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 140.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 533.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 112.20 Mn
10 Rallybio 91.28 Mn 91.28 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 12,000.00
Sep 30, 2022 4,000.00
Jun 30, 2022 14,000.00
Mar 31, 2022 36,000.00
Dec 31, 2021 137,000.00
Sep 30, 2021 130,000.00
Jun 30, 2021 4,000.00
Mar 31, 2021 62,000.00
Dec 31, 2020 106,000.00
Sep 30, 2020 23,000.00
API Access

Rallybio Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=RLYB&period=max&api_key=YOUR_API_KEY